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5-methylcytosine (5mC) is converted to 5-hydroxy-
methylcytosine (5hmC) by the TET family of en-
zymes as part of a recently discovered active
DNA de-methylation pathway. 5hmC plays impor-
tant roles in regulation of gene expression and
differentiation and has been implicated in T cell
malignancies and autoimmunity. Here, we report
early and widespread 5mC/5hmC remodeling dur-
ing human CD4+ T cell differentiation ex vivo at
genes and cell-specific enhancers with known
T cell function. We observe similar DNA de-methyl-
ation in CD4+ memory T cells in vivo, indicating
that early remodeling events persist long term in
differentiated cells. Underscoring their important
function, 5hmC loci were highly enriched for
genetic variants associated with T cell diseases
and T-cell-specific chromosomal interactions.
Extensive functional validation of 22 risk variants
revealed potentially pathogenic mechanisms in
diabetes and multiple sclerosis. Our results sup-
port 5hmC-mediated DNA de-methylation as a
key component of CD4+ T cell biology in humans,
with important implications for gene regulation
and lineage commitment.This is an open access article under the CC BY-NINTRODUCTION
Differentiation of CD4+ T cells into effector or regulatory sub-
types is critical to adaptive immunity. Upon contact with antigen,
T cells differentiate into various T helper (Th) cell subsets, such as
Th1, Th2, Th17, or regulatory T (Treg) cells (Yamane and Paul,
2013), which mediate or inhibit immune responses. Inappro-
priate CD4+ T cell differentiation is associated with several auto-
immune and inflammatory diseases, including rheumatoid
arthritis (RA), psoriasis, allergy, asthma, multiple sclerosis (MS),
and type 1 diabetes (Gustafsson et al., 2015; Licona-Limo´n
et al., 2013; Wahren-Herlenius and Do¨rner, 2013). The lack of a
strong genetic component and increasing prevalence of these
diseases suggests an epigenetic contribution to their pathogen-
esis, and changes in T cell DNA methylation patterns have been
reported in MS, allergy, and RA (Graves et al., 2013; Liu et al.,
2013; Nestor et al., 2014a).
Appropriate differentiation of Th cell subsets requires
widespread remodeling of the T cell epigenome, including
DNA de-methylation of key effector genes, such as Ifng and
Il4, Il5, and Il13 for Th1 and Th2, respectively (Janson et al.,
2011; Lee et al., 2006). 5-hydroxymethylcytosine (5hmC)
recently was discovered to be highly abundant in the human
genome and generated by hydroxylation of 5-methylcytosine
(5mC) by members of the Ten-Eleven-Translocation (TET1/2/3)
family of enzymes (Tahiliani et al., 2009). 5hmC subsequently
can be resolved to unmodified cytosine, completing the
process of DNA de-methylation (Figure S1A). Significantly, TETCell Reports 16, 559–570, July 12, 2016 ª 2016 The Author(s). 559
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
loss-of-function mutations have been identified in several hema-
tological malignancies, with the highest frequency in adult CD4+
T cell leukemias (Kalender Atak et al., 2012; Lemonnier et al.,
2012). Moreover, Tet2 knockout mice exhibited impaired differ-
entiation of hematopoietic stem cells and developed autoim-
mune phenotypes (Ichiyama et al., 2015; Ko et al., 2011; Li
et al., 2011; Yang et al., 2015). Despite the valuable insights
into the role of TET-5hmC during differentiation of mammalian
CD4+ T cells obtained from mouse models (Ichiyama et al.,
2015; Ko et al., 2011; Tsagaratou et al., 2014; Yang et al.,
2015), little is known about the importance of DNA de-methyl-
ation in human CD4+ T cell differentiation and its contribution
to the pathogenesis of complex immune diseases.
We generated genome-wide 5hmC, 5mC, and gene expres-
sion profiles during early and late stages of human CD4+ T cell
differentiation ex vivo. Changes in 5hmC were widespread dur-
ing both activation and differentiation of CD4+ T cells, occurred
at a variety of activating and repressive regulatory elements,
and coincided with tight regulation of TET gene expression.
Significantly, all early 5hmC and 5mC remodeling occurred in
the complete absence of replication, suggesting an active enzy-
matic remodeling mechanism. Using genetic overexpression,
we showed that tight regulation of TET levels was required for
appropriate expression of key lineage-specific transcription fac-
tors and cytokines. We confirmed these findings in vivo by tran-
scriptional and epigenetic profiling of human naive CD4+ (NT)
T cells and central memory (TCM) and effector memory (TEM)
T cells. Supporting the disease relevance of 5hmC-mediated
DNA de-methylation, loci gaining 5hmC during early T cell differ-
entiation were highly enriched for variants associated with T cell-
related diseases at a diversity of cis and trans gene-regulatory
elements. Moreover, these regions also were enriched for
T cell-specific chromosomal interactions, supporting their
importance in T cell biology. We undertook further functional
characterization of the effects of over 20 predicted regulatory
variants on the level of DNA-protein interactions, and we reveal
potentially pathogenic mechanisms in diabetes and MS. Our
results support 5hmC-mediated DNA de-methylation as a key
component of CD4+ T cell biology in humans and 5hmC profiling
as an effective approach for the identification of regulatory ge-
netic variants in complex immune disease.
RESULTS
5hmC Remodeling during CD4+ T Cell Differentiation
Occurs in the Absence of Replication and Is Enriched at
Key Regulatory Genes
To dissect the role of DNA de-methylation in human CD4+ T cell
function, we leveraged the ability to differentiate pure human NT
cells into Th cell subsets in vitro (Figure 1A). Appropriate differen-
tiation into Th1 and Th2 lineages was confirmed by gene expres-
sion microarray and qRT-PCR of key lineage-specific genes
(Figures S1B and S1C; Table S1). In vitro differentiation (polariza-
tion) of NT cells into Th1 and Th2 lineages resulted in a >5-fold
loss (p < 0.05, t test) of global 5hmC levels (Figure 1B). A small
but consistent 10%–15% loss of global 5hmC levels also was
observed after only 1 day of in vitro polarization before the onset
of DNA replication (Figures 1B, S1D, and S1E), suggesting DNA560 Cell Reports 16, 559–570, July 12, 2016replication-independent remodeling of 5hmC. To investigate
locus-specific remodeling of 5hmC, we combined 5hmC DNA
immunoprecipitation with massively parallel sequencing (hy-
droxymethylated DNA immunoprecipitation [hMeDIP]-seq) to
generate genome-wide 5hmC profiles in a time series of human
CD4+ T cells polarized toward Th1 and Th2 lineages. 5hmC pro-
files were generated for primary NT cells and at early (1-day) and
late (5-day) time points during polarization, allowing identifica-
tion of both early replication-independent changes as well as
late subset-specific changes in 5hmC. For each condition, 35–
60 million paired reads were generated, resulting in one billion
paired reads that were uniquely mapped to the human genome
(hg19) (Table S2). The 5hmC profiles showed characteristic
enrichment in gene bodies and depletion at transcription start
sites (TSSs), as previously reported in other cell types (Figure 1C),
as well as a clear association with actively transcribed genes
(Figure 1D) (Nestor et al., 2012; Song et al., 2011). Similar to re-
sults reported in mouse CD4+ T cells, the distribution of 5hmC
enrichment was significantly overrepresented in genic regions
in all conditions (Figure 1E; Table S2) (Ichiyama et al., 2015;
Tsagaratou et al., 2014).
To understand the biological relevance of these changes, we
mapped the 1,000 largest gains and losses of 5hmC to their
nearest gene and subjected these to gene ontology (GO) enrich-
ment analysis. Strikingly, whereas regions losing 5hmC were not
enriched in any biological processes, regions gaining 5hmC at
day 1 in either Th1 or Th2 cells were highly significantly
enriched for genes associated with T cell activation (adjusted
p < 1 3 108; Figure 1F; data not shown), including IFNG,
TBX21, FOXP3, ZAP70, IL2RA, IL7R, IRF4, CD5, AIM2, CCR2,
CCR5, IL1R2, IL26, and IL32R (Figure 1G; data not shown). Glob-
ally, large-scale remodeling of 5hmC had occurred by day 1, with
over 10,000 and 5,000 regions significantly gaining or losing
5hmC, respectively (Figure S1F; Table S2). The scale of change
was far greater in regions gaining 5hmC (Figure S1G).
Taken together, these results reveal genome-wide, replica-
tion-independent reprogramming of 5hmC during CD4+ T cell
differentiation at genes key to appropriate T cell activation and
differentiation.
Lineage Specification of Human CD4+ T Cells Is
Preceded by 5hmC-Mediated DNA De-methylation of
Gene-Regulatory Elements
To relate 5hmC remodeling during differentiation to changes in
DNAmethylation (5mC), we subjected the same in-vitro-differen-
tiated human Th1 and Th2 cells to DNA methylation profiling
using Infinium 450K methylation arrays. Although not genome-
wide, these arrays provide quantitative, base resolution methyl-
ation measurements at 450,000 CpG sites throughout the
genome, allowing accurate detection of even small (>3%)
changes in absolute methylation levels. We observed a clear
bias toward loss of 5mC in both Th1 and Th2 differentiated cells,
with more pronounced changes occurring by day 5 (Figure 2A).
However, some changes in DNAmethylation also were observed
at day 1 (123 CpGs > 10% loss, p < 0.05), in the complete
absence of DNA replication (Figure S2A; Table S3), suggesting
that such changes are active and not secondary to DNA replica-
tion. Importantly, regions gaining 5hmC at day 1 of differentiation
Figure 1. Dynamic Remodeling of 5hmC during In Vitro Polarization of Human CD4+ T Cells
(A) Schematic shows experimental design for T cell polarization.
(B) Global 5-hydroxymethylcytosine (5hmC) content measured by immuno-dot blot using a 5hmC antibody. Naive (NT) T cells were cultured under Th1- or
Th2-polarizing conditions for up to 5 days. Brain is shown as a tissue with high 5hmC content. Data are shown as mean ± SD, representative of five biological
replicates (*p < 0.05, Student’s t test).
(C) Normalized 5hmC density profiles across gene body ±4-kb flanking regions are shown.
(D) Normalized 5hmC density profiles across gene body ±2-kb flanking regions in NT cells binned into three equal sized groups, based on gene expression levels,
are shown.
(E) Genomic distribution of 5hmC peaks during T cell differentiation in vitro is shown (***p < 0.001, Fisher’s exact test).
(F) Gene ontology (GO) enrichment of 5hmC peaks in T cells differentiated in vitro for 1 day is shown.
(G) Coverage plots of 5hmC levels at IFNG, IL4, IL5, AIM2, and IL23R loci show subset-specific changes.
See also Figure S1.in both Th1 and Th2 cells were highly significantly enriched for
CpGs losing 5mC at day 5 (p < 0.0001, Fisher’s exact test) (Fig-
ures 2B and S2B), suggesting that DNA de-methylation at these
loci occurs primarily via a 5hmC-mediated process. Indeed, loci
showing the greatest loss of 5mC during Th1 and Th2 differenti-
ation were also those showing the greatest gains in 5hmC after
only 1 day of polarization (Figure 2C). Finally, genes showing
loss of DNA methylation (>30% loss of 5mC) in their promotersduring differentiation were enriched for functional terms related
to the immune response (Figure S2C), further indicating that
DNA de-methylation occurs in a targeted manner. Taken
together, these findings suggest a model whereby loci to be
de-methylated in differentiated T cell subtypes first undergo
enzymatic hydroxylation of 5mC to 5hmC, followed by both repli-
cation-independent excision and replication-dependent dilution
of 5hmC during successive rounds of DNA replication.Cell Reports 16, 559–570, July 12, 2016 561
Figure 2. DNA De-methylation Occurs via 5hmC during In Vitro Differentiation of Human CD4+ T Cells
(A) Volcano plot showing changes in DNAmethylation (5mC) during in vitro polarization of CD4+ T cells relative to NT cells. Vertical lines indicate a change of 20%.
5mC was measured by 450K methylation array.
(B) 5hmC regions show a major loss of 5mC during T cell polarization. Background represents a randomly sampled group with the same size of probes in 5hmC
peaks. Fisher’s exact test was used to calculate significance (rightmost).
(C) Line plot (top) shows that regions getting hypomethylated typically gain 5hmC at day 1 of T cell polarization. Boxplot (bottom) shows that genes associated
with regions becoming hypermethylated decrease in expression levels (***p < 0.001, one-way ANOVA Tukey’s test).
(D) Coverage plot showing active enhancers (H3K4me1 and H3K27ac) gaining 5hmC and losing 5mC during T cell polarization. Representative loci of AIM2 and
CCL5 are shown.
(E) Bar chart of 5mC changes in T cell-specific enhancer regions (H3K4me1 and H3K27ac) shows a higher degree of remodeling in these regions compared to
genome-wide. 5mC was measured by 450K methylation array.
(F and G) Distribution of 5mC changes at T cell-specific enhancers (H3K4me1 and H3K27ac) shows an early loss of 5mC in these regions.
See also Figure S2.As the majority (>95%) of loci undergoing 5hmC remodeling
during early CD4+ T cell differentiation occurred outside anno-
tated gene promoters, we hypothesized that these loci might
represent gene-regulatory elements. Indeed, the TET enzymes
interact with numerous chromatin modifiers (HDAC1, HDAC2,
EZH2, and SIN3A) and co-repressor complexes (NuRD), which562 Cell Reports 16, 559–570, July 12, 2016may serve to target TET methylcytosine dioxygenase activity to
regulatory elements within the genome (Delatte et al., 2014),
and elevated 5hmC levels have been observed at active en-
hancers in several systems (Lu et al., 2014; Tsagaratou et al.,
2014). Using published chromatin immunoprecipitation (ChIP)
sequencing (ChIP-seq) data, we analyzed the association
Figure 3. Tight Regulation of TET Gene Expression Is Required for Appropriate T Cell Differentiation
(A) Barplot shows TET1 gene expression in healthy human primary tissues (pool of at least five individuals) and primary immune cell subsets analyzed by qPCR.
(B and C) Barplots of TET gene expression measured by qPCR in NT cells cultured under Th1- or Th2-polarizing conditions. Expression levels are shown relative
to GUSB. Data are shown as mean ± SD, representative of three biological replicates (*p < 0.05 and **p < 0.01, Student’s t test).
(D) Schematic shows plasmids containing full-length TET1 (TET1fl), catalytic domain of TET1 (TET1cd), and mutated catalytic domain of TET1 (TET1mut).
(E and F) Barplots of gene expression for selected genes in NT cells transfected with TET1 plasmids and then cultured under Th1-polarizing conditions for 24 hr.
Lines indicate a log2 fold change of 0.5. Gene expression was measured by microarray.
See also Figure S3.between 5mC/5hmC remodeling in CD4+ T cells and the
enhancer-associated histone modifications, H3K4me1 and
H3K27ac (Hawkins et al., 2013) (Figure 2D). Indeed, Th1- and
Th2-specific active enhancer elements marked by H3K27ac
(Hawkins et al., 2013) were highly enriched for regions showing
5mC loss during differentiation (15-fold, p < 0.001) (Figures
2E–2G).
Ectopic Expression of TET1 Results in Dysregulation of
Key Cytokine and Chemokine Genes during
Differentiation
Expression profiling by qPCR showed that TET1, in contrast to
TET2 and TET3, was highly expressed in T cells, as well as
thymus compared to other human tissues and immune cells (Fig-
ures 3A and S3A). Moreover, whereas the absolute levels of
TET1 were lower than those of TET2 and TET3 during T cell dif-
ferentiation, TET1 alone underwent rapid and stable downregu-
lation during early T cell activation (>10-fold reduction; p < 0.01,
t test) (Figures 3B, 3C, and S3B). Indeed, TET1 silencing was
observed as early as 6 hr after the initiation of differentiation (Fig-
ure S3B). Unlike Tet2 and Tet3, Tet1 has been shown to bind to
Polycomb target gene promoters and associate with chromatin
repressors, thereby having a role in direct transcriptional repres-
sion unrelated to its enzymatic activity (Williams et al., 2011; Wu
et al., 2011). Thus, we sought to dissect the functional role of
TET1 during early T cell differentiation by ectopic expression of
full-length human TET1 (TET1fl) (Tahiliani et al., 2009), the cata-
lytic domain of TET1 (TET1cd), or a mutated catalytic domain
of TET1 (TET1mut) lacking enzymatic activity (Guo et al., 2011)(Figures 3D, S3C, and S3D). Notably, overexpression of TET1fl
led to significant dysregulation of chemokine and cytokine
gene mRNA levels (log2FC > 0.5), including several key regula-
tors of Th1/Th2 differentiation, IFNG, IL12RB2, HAVCR2,
GATA3, and IL5. (Figures 3E and S3E). Far fewer changes in
gene expression were observed with TET1cd (Figures 3F and
S3F; Table S4), the majority of which were associated with cal-
cium ion channel activity (Figure S3F). These findings suggest
that TET1 might act as a direct transcriptional repressor during
T cell differentiation. However, as the transcriptional programs
of each Th cell subset generally inhibit those of the other
lineages, future studies are warranted to fully elucidate the
functional role of TET1. Nevertheless, the results clearly support
an important role for TET1 in the regulation of key genes during
lineage-specification of Th cell subsets.
5hmCRemodeling during Early Differentiation of Human
CD4+ T Cells Predicts Loss of 5mC in CD4+ Memory
T Cells In Vivo
We and other have shown previously that adaptation of primary
mammalian cells to culture can affect the genomic distribution of
5hmC (Nestor et al., 2012, 2015). Thus, having determined the
DNA methylation dynamics of human T cell differentiation
in vitro, we sought to establish if similar changes occurred in vivo.
After activation and differentiation of NT cells, a small proportion
of cells remain as long-lived memory cell populations, which can
be sub-divided into TCM and TEM subsets based on their function
and homing capacity (Sallusto et al., 2004). We isolated prim-
ary human NT (CD4+CD45ROCCR7+), TCM (CD4
+CD45RO+Cell Reports 16, 559–570, July 12, 2016 563
Figure 4. Early DNA Methylation Remodeling Persists in CD4+ Memory T Cells In Vivo
(A) Barplot of TET gene expression in primary NT cells, central memory (TCM) cells, and effector memory (TEM) cells. Gene expression of TET1/2/3was measured
by qPCR.
(B) Barplot of global 5hmC content was measured by immuno-dot blot using a 5hmC antibody in primary NT, TCM, and TEM cells.
(C) Heatmap of gene expression in primary NT, TCM, and TEM cells showing subset-specific gene signatures. Gene expression was measured by microarray.
(D) Unsupervised hierarchical clustering of DNAmethylation (5mC) in NT, TCM, and TEM cells measured by 450Kmethylation array. Significancewas calculated by
bootstrap resampling.
(legend continued on next page)
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CCR7+), and TEM (CD4
+CD45RO+CCR7) cells by fluorescence-
activated cell sorting (FACS) (purity > 95%) for analysis (Fig-
ure S4A). Consistent with our findings in polarized T cells, in vivo
memory subsets exhibited decreased (p < 0.05, t test) levels of
TET1 and TET3 (Figure 4A) as well as lower global 5hmC content
(Figure 4B), verifying that TET inactivation events observed dur-
ing polarization also occur in vivo.
Next we generated gene expression and genome-wide DNA
methylation profiles for NT, TCM, and TEM cells. Gene expression
of TCM and TEM cells showed distinct profiles, with TEM cells ex-
pressing high levels of effector molecules, such as IL4, IFNG,
and CSF2, while TCM cells showed an intermediate profile,
both in expression levels and number of genes up- or downregu-
lated (Figures 4C, S4B, and S4C; Table S5), consistent with a
linear differentiation program of NT/ TCM/ TEM. Interestingly,
DNA methylation profiles could clearly separate NT, TCM, and
TEM cells, indicating that each subset is epigenetically distinct
(Figures 4D and S4D). Furthermore, TEM cells showed extensive
genome-wide de-methylation, exceeding that of TCM cells
(Figure 4E), consistent with the notion that TEM cells are more
terminally differentiated. As expected, DNAmethylation changes
in gene promoters were correlated with gene expression
(rho = 0.43, p = 5.9 3 1008) (Figure 4F).
Having characterized methylome- and transcriptome dy-
namics in memory T cells, we sought to relate these changes
to early hydroxymethylome reprogramming during T cell polari-
zation. Consistent with our findings in polarized T cells, regions
gaining 5hmC after 1 day of polarization exhibited extensive
de-methylation in memory cells (p = 6.203 1078, Fisher’s exact
test) (Figures 4G–4I). As 5hmC and 5mC cannot be distinguished
by conventional bisulfite conversion (Nestor et al., 2014b), we
performed 5hmC/5mC-specific qPCR for selected loci undergo-
ing 5mC changes in NT, TCM, and TEM cells (Figures S4E and
S4F; Table S6). Thus, early methylome-reprogramming events
initiated by 5hmC are maintained long term in memory T cells
in vivo.
5hmC Remodeling Marks Regulatory Regions Enriched
for Disease-Associated Genetic Variants
Consistent with previous reports in other cell types (Wu and
Zhang, 2014), 5hmC in CD4+ T cells marked several different
types of gene-regulatory elements (such as enhancers, pro-
moters, and gene bodies). Using a Hidden Markov model
together with published genome-wide datasets for several
epigenetic marks in primary human NT cells (Bernstein et al.,
2010; Song and Chen, 2015) (Table S7), we observed that
5hmC occupied a unique position in the genome, associating(E) Volcano plot of 5mC changes in memory subsets showing a predominant los
(F) Correlation between 5mC and gene expression in TEM cells calculated using S
gene expression was measured by microarray.
(G) 5hmC regions show major loss of 5mC in TEM cells. Background represen
Significance was calculated using Fisher’s exact test (rightmost).
(H) Venn diagram of sites losing 5mC in TEM cells and after 5 days of polarization to
versus NT for polarization and TEM, respectively, and p < 0.05. The p value for o
(I) Coverage plot of 5mC in NT, TCM, and TEM cells shows loss at representative lo
t test).
Data in (A) and (B) are shown as mean ± SD of at least three biological replicateswith both repressive and activating states, supporting the prop-
erty of 5hmC as a general marker of gene-regulatory activity (Fig-
ure 5A). Since the majority of disease-associated variants are
found in non-coding regions, we compared the frequency of all
disease-associated variants reported at the time of analysis
(NleadVariant = 73,196; p < 1 3 10
5, GWASdb2) (Li et al., 2012)
and those in high linkage disequilibrium (LD) (NVARIANT =
600,320, r2 > 0.8, 1000 Genomes Project, phase 3) in regions
gaining or losing 5hmC at day 1 of in vitro polarization, resulting
in a total of 1,560 variants (Table S8). Regions gaining 5hmC
(hereafter referred to as 5hmC regions) were significantly en-
riched (p < 0.01) for disease-associated variants in 19 diseases,
where six of the top ten diseases were autoimmune, whereas re-
gions losing 5hmC showed no significant enrichment for CD4+
T cell diseases (Figure 5B). Strikingly, regions gaining 5hmC
were twice as likely (odds ratio [OR] 2.6, p < 0.0001, Fisher’s
exact test) to overlap a disease-associated variant than cell-
type-specific enhancers (Figure 5C) (Hawkins et al., 2013).
Previously, 5hmC has been associated with transcription
factor-binding sites (TFBSs) (Yu et al., 2012), suggesting that
variants in 5hmC regions may modulate gene expression by
disrupting TF binding. We tested all 1,560 5hmC variants us-
ing phylogenetic module complexity analysis (PMCA),
leveraging the conservation of co-occurring TFBS patterns
within gene-regulatory modules, as previously described by
us (Claussnitzer et al., 2014). Interestingly, for the variants in
5hmC regions, we found 49.4% predicted to be regulatory
compared to our previous findings of 33.3% in a random set
of variants (Claussnitzer et al., 2014) (Table S8). To experi-
mentally evaluate the effects of identified non-coding variants
on regulatory protein binding, we performed electrophoretic
mobility shift assays (EMSAs) using nuclear protein extracts
from both transformed and primary, trait-related human
CD4+ T cells, with probes for the risk and non-risk alleles of
22 variants (44 alleles) (Table S9). First, we tested variants
associated with Crohn disease and MS, as these diseases
showed the highest enrichment for variants in 5hmC regions
(Figure 5B; Table S8). We also tested variants associated
with non-enriched T cell-associated diseases (such as allergy)
and other non-T cell-associated traits (obesity and metabolite
levels) with high TFBS module conservation (Figure 5B; Table
S8). We found an allele-specific shift in 16 of 22 tested vari-
ants when using protein extracts from the Jurkat T cell line
(Figures 5D and S5A), supporting that 5hmC can aid in the
identification of regulatory variants, potentially contributing
to disease pathophysiology. Importantly, variant-induced al-
terations on regulator binding could be replicated by usings in both TCM and TEM cells. Vertical lines indicate a change of 30%.
pearman’s rank-correlation coefficient. 5mC was measured by 450k array and
ts a randomly sampled group with the same size of probes in 5hmC peaks.
ward Th1 and Th2. Sites losing 5mCwere defined as a loss of 20%or 30%5mC
verlaps was calculated using Fisher’s exact test.
ci marked by 5hmC during in vitro polarization of T cells (***p < 0.001, Student’s
(*p < 0.05, **p < 0.01, and ***p < 0.001, Student’s t test).
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Figure 5. 5hmC Regions Are Highly Enriched for Disease-Associated Variants
(A) ChromHMM heatmap shows enrichment and colocalization of 5hmC with other epigenetic marks in NT cells.
(B) Enrichment of disease-associated variants in peaks gaining (left) and losing (right) 5hmc after 1 day of CD4+ T cell polarization is shown.
(legend continued on next page)
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nuclear protein from primary human CD4+ T cells isolated
from healthy individuals (Figure 5E).
As none of the risk variants affecting regulator binding were
located within gene promoters or gene-coding regions, we as-
sessed how risk variants might modulate gene expression via
physical interaction with distal gene-regulatory elements. Using
chromatin interaction data (capture Hi-C [cHi-C]) for a human
CD4+ T cell line (Martin et al., 2015), we found that disease-
associated variants located in 5hmC regions were significantly
enriched (bootstrap p < 1 3 104) for long-range chromatin in-
teractions compared to all disease-associated variants (Fig-
ure 5F). Interestingly, enrichment of chromatin interactions for
disease-associated variants in 5hmC regions was greater
than that observed for T cell-specific enhancers (Hawkins
et al., 2013), even though, not surprisingly, enhancer regions
alone had a significantly higher number of chromatin interac-
tions compared to 5hmC regions (Figure 5F; data not shown).
These findings strongly support the power of 5hmC as a pre-
cise and efficient marker to identify regulatory disease-associ-
ated variants.
To further validate our approach, we examined interactions at
the CLEC16A locus, which is associated with several autoim-
mune diseases (Wellcome Trust Case Control, 2007) (Figure 5G).
Of 30 variants in high LD (r2 > 0.8), five were located in 5hmC re-
gions, two of which were significantly enriched for TFBS module
conservation (Table S8). For these two variants, we observed dif-
ferential protein binding for rs7203150 in both Jurkat and primary
humanCD4+ cells (Figures 5D and 5E; p = 5.93 107/1.83 103,
respectively, Student’s t test), whereas no allele-specific binding
was observed for rs7198004 (Table S8; Figure S5A). The variant
rs7203150 is located in intron 19 of the CLEC16A gene, contain-
ing many variants associated with multiple autoimmune dis-
eases, and has been shown to physically interact with and
regulate the expression of a neighboring gene, DEXI (Davison
et al., 2012). The cHi-C data confirmed the highly significant
interaction of the rs7203150 region with theDEXI promoter (false
discovery rate [FDR] < 5%), as expected, but also revealed other
interactions with a downstream gene, RMI2 (Figure 5G). In fact,
cHi-C data suggest interactions for numerous genes at the
CLEC16A locus, including SOCS1, a negative regulator of cyto-
kine signaling (Diehl et al., 2000); DEXI, a gene of unknown func-
tion but proposed as autoimmune candidate gene (Leikfoss
et al., 2013); RMI2, a topoisomerase critical for T cell differentia-
tion and a primary immunodeficiency syndrome candidate gene
(Mo¨nnich et al., 2010); and CLEC16A, recently shown to affect
T cell selection, mediate T1D, and modify CD4 single-positive
thymocyte reactivity (Schuster et al., 2015) (Figure 5G). Finally,
in our T cell data we find supportive co-expression of CLEC16A
with SOCS1, DEXI, and RMI2 (Figure 5G, right panel).(C) Venn diagram shows disease-associated variant localization in 5hmC 1-day
(D and E) EMSA analysis of protein-DNA binding showing changes in binding up
protein extracts from Jurkat T cell line (D) and primary CD4+ T cells (E). Dashed bo
(F) Barplot of capture Hi-C (cHi-C) interactions overlapping variants in identified
bias and p values were calculated using bootstrap resampling (n = 10,000).
(G) Genomic plot of variant rs7203150 located in identified 5hmC region showing in
T cell polarization shows high degree of co-expression between genes interactin
See also Figure S5.Thus, 5hmC remodelingmarks cell-type-specific gene-regula-
tory regions, whichmay contribute to pathogenic mechanisms in
CD4+ T cell-associated diseases.
DISCUSSION
Previous studies of 5hmC during T cell differentiation have re-
ported global loss of 5hmC in differentiated Th cell subsets in
mouse (Ichiyama et al., 2015; Tsagaratou et al., 2014; Yang
et al., 2015). We confirm these findings, but using a time
series-profiling approach, we also report widespread 5hmC re-
modeling during early differentiation, including >10,000 locus-
specific gains of 5hmC enriched at genes associated with
T cell function. We reveal that 5hmC-mediated DNA de-methyl-
ation is a key feature of human CD4+ T cell differentiation and
that tight regulation of TET gene expression is critical for appro-
priate differentiation of Th cell subsets. These DNA de-methyl-
ation events also were observed in memory T cells in vivo, and
they were enriched for variants associated with CD4+ T cell
diseases, including MS, psoriasis, and Crohn disease. Several
disease-associated variants affected DNA-protein interactions
in primary human CD4+ T cells, revealing potentially pathogenic
mechanisms in several autoimmune diseases. As 5hmC profiling
can be performed on small amounts (>25 ng) of archived, frag-
mented genomic DNA, it is ideal for identifying and stratifying po-
tential regulatory variants in rare primary cell types (Taiwo et al.,
2012). This is in contrast to chromatin-based enhancer-profiling
strategies, which typically require profiling of multiple epigenetic
marks in large amounts of fresh material (Hawkins et al., 2013).
Studies in mouse have provided valuable insights into the role
of DNA methylation during differentiation of mammalian CD4+
T cells, but less is known about the importance of DNA de-
methylation in human CD4+ T cell differentiation and its contribu-
tion to the pathogenesis of complex immune diseases (Ichiyama
et al., 2015; Ko et al., 2011; Tsagaratou et al., 2014; Yang et al.,
2015). Our profiling of the methylome (5mC), hydroxymethylome
(5hmC), and transcriptome of matched human CD4+ T cells
during in vitro differentiation of NT cells into Th1 and Th2 cells re-
vealed widespread remodeling of 5hmC during early T cell
activation, and it showed that early gains in 5hmC predicted sub-
sequent loss of 5mC in differentiated Th1 and Th2 cells. Signifi-
cantly, 5hmC remodeling was enriched in the regulatory regions
of genes with known T cell function, including master regulators
of lineage specification, such as IFNG, TBX21, and FOXP3.
Consistent with an important role for 5hmC-mediated DNA de-
methylation in T cell differentiation, we found that (1) the TET
genes are most highly expressed in T cell-related tissues
(CD4+ T cells, CD8+ T cells, and thymus) in humans, (2) CD4+
T cell activation results in dramatic (10-fold) and rapid (6-hr)gain peaks and CD4+ T cell enhancers.
on introduction of disease-associated variants in 5hmC regions using nuclear
xes indicate shifts in binding and arrows indicate shifts not observed in cell line.
5hmC regions or T cell enhancers. Region sizes were normalized to avoid size
teractions with nearby gene promoters (left). Heatmap of co-expression during
g with variant rs7203150 (right). cHi-C, capture Hi-C.
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downregulation of TET1 expression, and (3) dysregulation of
TET1 expression disrupts CD4+ T cell differentiation. These ob-
servations are consistent with a growing number of studies in
Tet knockout mice, which have revealed a pivotal role of TET
enzymatic activity in T cell biology (Ichiyama et al., 2015; Ko
et al., 2010; Tsagaratou et al., 2014; Yang et al., 2015).
In addition to direct differentiation into effector subtypes, a
proportion of activated NT cells become long lived and retain
memory of the initial activating signal (Sallusto et al., 1999).
Methylome profiling of NT, TCM, and TEM cells ex vivo revealed
that the DNA methylation changes observed early during differ-
entiation persist in memory T cells. First, this important observa-
tion supports the validity of in vitro CD4+ T cell differentiation as a
powerful model system in which to study the epigenetics of
human CD4+ T cells. Second, these data suggest that any dys-
regulation of the DNA de-methylation pathway not only affects
immediate response to antigen (differentiation) but also appro-
priate formation of T cell memory.
The availability of global profiles for several activating and
repressive epigenetic marks allowed us to study the epigenetic
neighborhood occupied by 5hmC in human CD4+ T cells. We
used a recently described Hidden Markov model-based
approach to identify the distinct chromatin states present in hu-
man NT cells (Song and Chen, 2015). Interestingly, instead of
simply following the patterning of 5mC, from which it is derived,
5hmC was present in chromatin states composed of activating,
repressive, and poised histone modifications (Figure 5A).
5hmC’s presence across so many chromatin states may reflect
its property as an intermediate during conversion of transcrip-
tionally repressive 5mC to transcriptionally permissive unmodi-
fied cytosine (Hon et al., 2014). Alternatively, 5hmC’s association
with such a diverse range of histone marks may reflect the
growing realization of the TET enzymes as multi-faceted pro-
teins, connecting different layers of epigenetic and transcription
control to maintain cell state (Laird et al., 2013). Indeed, the TET
enzymes have been reported to directly interact with transcrip-
tional activators, including PU.1, EBF1, and p300, while also
interacting with proteins associated with transcriptional repres-
sion, including EZH2, SIN3A, HDACs, NuRD, and MeCP2 (Car-
tron et al., 2013; Delatte et al., 2014).
Regardless of the underlying mechanism, 5hmC’s position as
a general but sensitive indicator of chromatin state makes it a
powerful tool in the identification of cell-type-specific regulatory
elements. Indeed, regions gaining 5hmC during early activation
(day 1) were highly enriched for variants associated with several
autoimmune diseases, including Crohn disease, MS, celiac dis-
ease, myasthenia gravis, and psoriasis. The effect of these
potentially regulatory variants on DNA-protein binding was
directly tested in primary human CD4+ T cells, and it provides
multiple molecular pathways for further investigation. By
combining these results with chromatin interaction (cHi-C) data
from a human T cell line, we found that 5hmC variants are en-
riched for connections between distal regulatory elements, and
we identified several interactions, which, if disrupted by risk var-
iants, may have pathogenic consequences in autoimmune dis-
ease. Combined with the ability to perform 5hmC profiling on
small amounts of archived DNA, this surprising and provocative
finding suggests that 5hmC alone may be a powerful and cost-568 Cell Reports 16, 559–570, July 12, 2016effective approach for the prioritization of regulatory variants in
humans.
In conclusion, 5hmC-mediated DNA de-methylation plays key
roles in the differentiation of human CD4+ T cells, marking
regions relevant for the pathogenesis of several autoimmune dis-
eases, and it is an effective and accessible approach for identi-
fying causal disease variants in autoimmune disease.
EXPERIMENTAL PROCEDURES
Ethics Statement
This study was approved by the ethics board of Linko¨ping University and all
participants provided written consent for participation.
Cell Isolation and Stimulation
Peripheral blood mononuclear cells (PBMCs) were enriched from healthy
donor buffy coats using Lymphoprep (Axis-shield). Human total CD4+ T cells
or NT cells then were isolated through magnetic sorting (Miltenyi Biotec). NT
cells were cultured with plate-bound anti-CD3 (500 ng/ml) and soluble anti-
CD28 (500 ng/ml) in the presence of IL-12 (5 ng/ml), IL-2 (10 ng/ml), and anti-
IL4 (5 mg/ml) for Th1 or IL-4 (10 ng/ml), IL-2 (10 ng/ml), anti-IFNG (5 mg/ml),
and anti-IL12 (5 mg/ml) for Th2 conditions. Cells were grown for up to 5 days
in RPMI-1640 medium (Life Technologies) supplemented with 2 mM L-gluta-
mine (PAA Laboratories), 10% heat-inactivated fetal calf serum (FCS, PAA
Laboratories), and 50 mg/ml gentamicin (Sigma-Aldrich). Cells were re-stimu-
lated with respective condition (see above) after 3 days in culture.
DNA and RNA Extractions
Total RNA and genomic DNA were extracted using AllPrep DNA/RNA mini kit
(QIAGEN). DNA and RNA integrity was determined using a 2100 Bioanalyzer
(Agilent Technologies).
hMeDIP-Seq and Data Analysis
DNA (1.5 mg) was fragmented by sonication using a Bioruptor (63 15 min/30 s
on/off, Diagenode), and then it was subjected to end repair, dA tailing, and
adaptor ligation using the NEBNext DNA Library Prep Master Mix Set for
Illumina (New England Biolabs). Samples were subjected to hMeDIP as previ-
ously described (Nestor et al., 2012). Briefly, DNA was denatured and incu-
bated with 1 mg antibody against 5hmC (ActiveMotif, 39769) overnight at
4C. Immunoprecipitate and input DNA were prepared using magnetic beads
(Dynabeads Protein G, Invitrogen) and amplified using NEBNext Multiplex
Oligos for Illumina (New EnglandBiolabs). Samples were separated by electro-
phoresis on a 2% low-melting-point agarose gel and fragments between 100
and 400 bpwere selected. DNAwas purified using the QIAquick Gel Extraction
Kit (QIAGEN) and paired-end reads were sequenced on an Illumina HiSeq
2000 platform at the Beijing Genomics Institute. Reads were mapped to the
human genome (hg19) using bowtie2 fast read aligner with the following pa-
rameters (bowtie –v 1 – best -S).
Peak calling was performed using model-based analysis of ChIP-seq
(MACS) with input samples as controls. NT input was used as input control
for both NT and day 1 IP samples. Day 5 input was used as input control for
day 5 IP samples. Differential analysis of hMeDIP-seq between conditions
was performed using macs2diff algorithm, a sub-program of the MACS soft-
ware using a standard window size of 200 bp (Zhang et al., 2008). Metagene
plots of average 5hmC enrichment were created using the ngs.plot software
(Shen et al., 2014). Overlap of 5hmC peaks with different genomic compart-
ments was performed using the intersect function within the bedtools suite
of programs (Quinlan and Hall, 2010). Merging of intervals from replicate
experiments was performed using the merge function, also within bedtools.
Human transcript coordinates were obtained from the refGene database
(UCSC Genome Browser, hg19, May 2015; https://genome.ucsc.edu).
Immuno-dot Blotting
DNA was denatured and applied to a positively charged nylon membrane un-
der vacuum using a Dot Blot Hybridization Manifold (Harvard Apparatus). The
membrane was washed twice in 2X SSC buffer, air dried, and UV crosslinked.
Membranes were incubated with an antibody against 5hmC (1:3,000, Active
Motif) for 1 hr at 4C, then washed in TBS-Tween (0.05%), and incubated
with a horseradish peroxidase (HRP)-conjugated goat-anti-rabbit antibody
(1:10,000, Bio-Rad). Following treatment with enhanced chemiluminescence
(ECL) substrate, membranes were scanned on a ChemiDoc MP imaging sys-
tem (Bio-Rad). To control for loading, membraneswere stainedwithmethylene
blue. Spot intensities were quantified using ImageJ (NIH).
Gene Expression Microarrays and Analysis
For gene expression microarrays, RNA was labeled and amplified using the
Low Input Quick Amp Labeling kit (Agilent Technologies), then hybridized
onto SurePrint G3 Human Gene Expression 8x60K v2 microarrays (Agilent
Technologies), and scanned using a Surescan High Resolution DNA Microar-
ray Scanner (Agilent Technologies). Raw intensities were exported with
Agilent’s Feature Extraction Software. All subsequent analyses were per-
formed using the LIMMA package in the R statistical programming language.
Briefly, data were background corrected and quantile normalized; then control
probes, probes not expressed (background +10%) in all conditions, and non-
annotated probes were removed.
Statistical Analysis
The p values < 0.05 were considered significant and, when stated, p values
were adjusted using Benjamini-Hochberg correction.
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